位置:首页 > 蛋白库 > CILK1_MOUSE
CILK1_MOUSE
ID   CILK1_MOUSE             Reviewed;         629 AA.
AC   Q9JKV2; Q8K138;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 2.
DT   03-AUG-2022, entry version 155.
DE   RecName: Full=Serine/threonine-protein kinase ICK;
DE            EC=2.7.11.1 {ECO:0000269|PubMed:24797473};
DE   AltName: Full=Intestinal cell kinase;
DE            Short=mICK;
DE   AltName: Full=MAK-related kinase;
DE            Short=MRK;
GN   Name=Cilk1; Synonyms=Ick;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|EMBL:AAF37277.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Ileum {ECO:0000269|PubMed:10699974}, and
RC   Jejunum {ECO:0000269|PubMed:10699974};
RX   PubMed=10699974;
RX   DOI=10.1002/(sici)1097-4652(200004)183:1<129::aid-jcp15>3.0.co;2-s;
RA   Togawa K., Yan Y.-X., Inomoto T., Slaugenhaupt S.A., Rustgi A.K.;
RT   "Intestinal cell kinase (ICK) localizes to the crypt region and requires a
RT   dual phosphorylation site found in map kinases.";
RL   J. Cell. Physiol. 183:129-139(2000).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon {ECO:0000312|EMBL:AAH28863.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 152-163, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY,
RP   AUTOPHOSPHORYLATION, MUTAGENESIS OF LYS-33; 157-THR--TYR-159; GLU-169;
RP   TRP-184; LYS-270; LYS-271 AND ARG-272, PHOSPHORYLATION AT THR-157 AND
RP   TYR-159, AND MASS SPECTROMETRY.
RX   PubMed=15988018; DOI=10.1128/mcb.25.14.6047-6064.2005;
RA   Fu Z., Schroeder M.J., Shabanowitz J., Kaldis P., Togawa K., Rustgi A.K.,
RA   Hunt D.F., Sturgill T.W.;
RT   "Activation of a nuclear Cdc2-related kinase within a mitogen-activated
RT   protein kinase-like TDY motif by autophosphorylation and cyclin-dependent
RT   protein kinase-activating kinase.";
RL   Mol. Cell. Biol. 25:6047-6064(2005).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-157; TYR-159 AND SER-161, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, Pancreas, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND SUBCELLULAR LOCATION.
RX   PubMed=24797473; DOI=10.1002/embj.201488175;
RA   Chaya T., Omori Y., Kuwahara R., Furukawa T.;
RT   "ICK is essential for cell type-specific ciliogenesis and the regulation of
RT   ciliary transport.";
RL   EMBO J. 33:1227-1242(2014).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-33.
RX   PubMed=25243405; DOI=10.1371/journal.pone.0108470;
RA   Broekhuis J.R., Verhey K.J., Jansen G.;
RT   "Regulation of cilium length and intraflagellar transport by the RCK-
RT   kinases ICK and MOK in renal epithelial cells.";
RL   PLoS ONE 9:E108470-E108470(2014).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND SUBCELLULAR LOCATION.
RX   PubMed=24853502; DOI=10.1073/pnas.1323161111;
RA   Moon H., Song J., Shin J.O., Lee H., Kim H.K., Eggenschwiller J.T., Bok J.,
RA   Ko H.W.;
RT   "Intestinal cell kinase, a protein associated with endocrine-cerebro-
RT   osteodysplasia syndrome, is a key regulator of cilia length and Hedgehog
RT   signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:8541-8546(2014).
RN   [8]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=29539279; DOI=10.1056/nejmoa1700175;
RA   Bailey J.N., de Nijs L., Bai D., Suzuki T., Miyamoto H., Tanaka M.,
RA   Patterson C., Lin Y.C., Medina M.T., Alonso M.E., Serratosa J.M.,
RA   Duron R.M., Nguyen V.H., Wight J.E., Martinez-Juarez I.E., Ochoa A.,
RA   Jara-Prado A., Guilhoto L., Molina Y., Yacubian E.M., Lopez-Ruiz M.,
RA   Inoue Y., Kaneko S., Hirose S., Osawa M., Oguni H., Fujimoto S.,
RA   Grisar T.M., Stern J.M., Yamakawa K., Lakaye B., Delgado-Escueta A.V.;
RT   "Variant intestinal-cell kinase in juvenile myoclonic epilepsy.";
RL   N. Engl. J. Med. 378:1018-1028(2018).
CC   -!- FUNCTION: Has an essential role in ciliogenesis, particularly in
CC       neuronal and retinal progenitor cells (PubMed:24797473). Phosphorylates
CC       KIF3A (PubMed:24797473). Involved in the control of ciliary length
CC       (PubMed:24853502). Regulates the ciliary localization of SHH pathway
CC       components as well as the localization of IFT components at ciliary
CC       tips (PubMed:24797473, PubMed:24853502). May play a role in cardiac
CC       development (By similarity). Regulates intraflagellar transport (IFT)
CC       speed and negatively regulates cilium length in a cAMP and mTORC1
CC       signaling -dependent manner and this regulation requires its kinase
CC       activity (PubMed:25243405). {ECO:0000250|UniProtKB:Q62726,
CC       ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:24853502,
CC       ECO:0000269|PubMed:25243405}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:15988018, ECO:0000269|PubMed:24797473};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:15988018,
CC         ECO:0000269|PubMed:24797473};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:24797473};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol
CC       {ECO:0000250|UniProtKB:Q62726}. Cell projection, cilium
CC       {ECO:0000269|PubMed:24797473, ECO:0000269|PubMed:25243405}. Nucleus
CC       {ECO:0000269|PubMed:15988018, ECO:0000269|PubMed:25243405}. Cytoplasm,
CC       cytoskeleton, cilium basal body {ECO:0000269|PubMed:24853502}.
CC       Note=Also found at the ciliary tip (PubMed:24797473). Predominant
CC       nuclear localization has been observed with a N-terminally GFP-tagged
CC       construct in transfected COS-7 cells (PubMed:15988018).
CC       {ECO:0000269|PubMed:15988018, ECO:0000269|PubMed:24797473}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in colon and lung, lower levels
CC       present in heart, esophagus, stomach, small intestine and ovary.
CC       Localizes to the crypt region of large and small intestine.
CC       {ECO:0000269|PubMed:10699974}.
CC   -!- DEVELOPMENTAL STAGE: At 14.5 dpc, expressed in the brain cortex,
CC       including the cortical plate, intermediate zone, and ventricular and
CC       subventricular zones. {ECO:0000269|PubMed:29539279}.
CC   -!- PTM: Autophosphorylated on serine and threonine residues.
CC       Phosphorylation at Thr-157 by CDK7/Cak1p increases kinase activity.
CC       {ECO:0000269|PubMed:15988018}.
CC   -!- DISRUPTION PHENOTYPE: Knockout mice manifest hydrocephalus,
CC       polydactyly, and delayed skeletal development. At cellular levels, ICK
CC       knockout results in abnormally elongated cilia and compromised SHH
CC       signaling. {ECO:0000269|PubMed:24853502}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF225918; AAF37277.1; -; mRNA.
DR   EMBL; BC028863; AAH28863.1; -; mRNA.
DR   CCDS; CCDS40697.1; -.
DR   RefSeq; NP_001157252.1; NM_001163780.1.
DR   RefSeq; NP_064371.2; NM_019987.2.
DR   RefSeq; XP_006511367.1; XM_006511304.2.
DR   AlphaFoldDB; Q9JKV2; -.
DR   SMR; Q9JKV2; -.
DR   STRING; 10090.ENSMUSP00000048234; -.
DR   iPTMnet; Q9JKV2; -.
DR   PhosphoSitePlus; Q9JKV2; -.
DR   jPOST; Q9JKV2; -.
DR   MaxQB; Q9JKV2; -.
DR   PaxDb; Q9JKV2; -.
DR   PRIDE; Q9JKV2; -.
DR   ProteomicsDB; 267186; -.
DR   ABCD; Q9JKV2; 1 sequenced antibody.
DR   Antibodypedia; 605; 300 antibodies from 24 providers.
DR   DNASU; 56542; -.
DR   Ensembl; ENSMUST00000044551; ENSMUSP00000048234; ENSMUSG00000009828.
DR   Ensembl; ENSMUST00000118869; ENSMUSP00000112961; ENSMUSG00000009828.
DR   GeneID; 56542; -.
DR   KEGG; mmu:56542; -.
DR   UCSC; uc009qtt.2; mouse.
DR   CTD; 22858; -.
DR   MGI; MGI:1934157; Cilk1.
DR   VEuPathDB; HostDB:ENSMUSG00000009828; -.
DR   eggNOG; KOG0661; Eukaryota.
DR   GeneTree; ENSGT00940000158807; -.
DR   InParanoid; Q9JKV2; -.
DR   OMA; RYTNIRQ; -.
DR   OrthoDB; 76933at2759; -.
DR   PhylomeDB; Q9JKV2; -.
DR   TreeFam; TF328769; -.
DR   BioGRID-ORCS; 56542; 4 hits in 75 CRISPR screens.
DR   PRO; PR:Q9JKV2; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q9JKV2; protein.
DR   Bgee; ENSMUSG00000009828; Expressed in trigeminal ganglion and 237 other tissues.
DR   ExpressionAtlas; Q9JKV2; baseline and differential.
DR   Genevisible; Q9JKV2; MM.
DR   GO; GO:0036064; C:ciliary basal body; IDA:UniProtKB.
DR   GO; GO:0097546; C:ciliary base; IDA:UniProtKB.
DR   GO; GO:0097542; C:ciliary tip; IMP:UniProtKB.
DR   GO; GO:0005929; C:cilium; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0001650; C:fibrillar center; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; ISO:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:MGI.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0035720; P:intraciliary anterograde transport; IMP:UniProtKB.
DR   GO; GO:0035721; P:intraciliary retrograde transport; IMP:UniProtKB.
DR   GO; GO:0042073; P:intraciliary transport; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:MGI.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell projection; Cilium biogenesis/degradation; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Direct protein sequencing; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..629
FT                   /note="Serine/threonine-protein kinase ICK"
FT                   /id="PRO_0000086008"
FT   DOMAIN          4..284
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000305"
FT   REGION          292..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          455..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          581..629
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        328..343
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        125
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         10..18
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P06493,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         33
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NYX3,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         157
FT                   /note="Phosphothreonine; by CDK7"
FT                   /evidence="ECO:0000269|PubMed:15988018,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         159
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:15988018,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         161
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         33
FT                   /note="K->M: No effect on cilium length."
FT                   /evidence="ECO:0000269|PubMed:25243405"
FT   MUTAGEN         33
FT                   /note="K->R: Loss of kinase activity; no effect on nuclear
FT                   subcellular location."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         157..159
FT                   /note="TDY->ADF: Loss of kinase activity and of
FT                   autophosphorylation; loss of phosphorylation by CDK7; no
FT                   effect on nuclear subcellular location."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         157
FT                   /note="T->A: Loss of kinase activity; loss of
FT                   phosphorylation by CDK7; no effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         159
FT                   /note="Y->F: Loss of kinase activity and of
FT                   autophosphorylation; no effect on phosphorylation by CDK7."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         169
FT                   /note="E->A: Complete loss of kinase activity and of
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         184
FT                   /note="W->A: Complete loss of kinase activity and of
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         270
FT                   /note="K->A: Partial loss of autocatalytic kinase activity.
FT                   Complete loss of kinase activity and of nuclear
FT                   localization; when associated with A-271 and A-272."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         271
FT                   /note="K->A: Partial loss of kinase activity. Complete loss
FT                   of kinase activity and of nuclear localization; when
FT                   associated with A-270 and A-272."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   MUTAGEN         272
FT                   /note="R->A: Complete loss of kinase activity and of
FT                   nuclear localization. Complete loss of kinase activity and
FT                   of nuclear localization; when associated with A-270 and A-
FT                   272."
FT                   /evidence="ECO:0000269|PubMed:15988018"
FT   CONFLICT        533
FT                   /note="S -> R (in Ref. 1; AAF37277)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        616
FT                   /note="H -> L (in Ref. 1; AAF37277)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   629 AA;  70592 MW;  43E863847C5FD9C5 CRC64;
     MNRYTTIKQL GDGTYGSVLL GRSIESGELI AIKKMKRKFY SWEECMNLRE VKSLKKLNHA
     NIVKLKEVIR ENDHLYFIFE YMKENLYQLI KERNKLFPES AIRNIMYQIL QGLAFIHKHG
     FFHRDLKPEN LLCMGPELVK IADFGLAREI RSRPPYTDYV STRWYRAPEV LLRSTNYSSP
     IDIWAVGCIM AEVYTLRPLF PGASEIDTIF KICQVLGTPK KTDWPEGYQL SSAMNFLWPQ
     CIPNNLKTLI PNASSEAIQL LRDLLQWDPK KRPTASQALR YPYFQIGHPL GIISKDSGKP
     QREVQDKTGP PPYIKPAPPA QAPAKAYTLI SSRPSQASQP PQHSVHPYKG DVSRTEQLSH
     VQEGKPSPPF FPSLHNKNLQ PKILASLEQK NGEIKPKSRR RWGLISRSTK GSDDWADLDD
     LDFSPSLTRI DVKNKKRQSD DTLCRFESVL DLKPSESVGT GTTVSTQASS QRRDTPTLQS
     SAKQHYLKHS RYLPGINIRN GVLPNPGKDF LPSNSWSSSG LSGKSSGTVS VVSKITSVGS
     GSASSSGLTG SYIPSFLKKE IGSVMQRVQL APLAAPPPGY SSLKAVRPHP GRPFFHTQPR
     STPGLIPRPP AAQPVHGRID WSSKYPSRR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024